Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Mar 28;23(12):2175-2184.
doi: 10.3748/wjg.v23.i12.2175.

Acanthopanax senticosus polysaccharides-induced intestinal tight junction injury alleviation via inhibition of NF-κB/MLCK pathway in a mouse endotoxemia model

Affiliations

Acanthopanax senticosus polysaccharides-induced intestinal tight junction injury alleviation via inhibition of NF-κB/MLCK pathway in a mouse endotoxemia model

Jie Han et al. World J Gastroenterol. .

Abstract

Aim: To examine the effects of Acanthopanax senticosus polysaccharides (ASPS) on intestinal tight junction (TJ) disruption and nuclear factor-kappa B (NF-κB)/myosin light chain kinase (MLCK) activation in endotoxemia.

Methods: BALB/C mice (6-8-weeks-old) received continuous intragastric gavage of ASPS for 7 d before injection of lipopolysaccharide (LPS), or received ASPS once after LPS injection. Blood and intestinal mucosal samples were collected 6 h after LPS challenge. Clinical symptoms, histological injury, intestinal permeability, TJ ultrastructure, and TJ protein expression were determined.

Results: Compared with mice in the LPS group, pretreatment with ASPS improved clinical and histological scores by 390.9% (P < 0.05) and 57.89% (P < 0.05), respectively, and gut permeability change in endotoxemic mice was shown by a 61.93% reduction in reduced leakage of fluorescein isothiocyanate-dextran 6 h after LPS injection (P < 0.05). ASPS pretreatment also prevented LPS-induced TJ ultrastructure breakdown supported by increased electron dense materials between adjoining cells, sustained redistribution and expression of occludin (0.597 ± 0.027 vs 0.103 ± 0.009, P < 0.05) and zonula occludens-1 (0.507 ± 0.032 vs 0.125 ± 0.019, P < 0.05), and suppressed activation of the NF-κB/MLCK pathway indicated by reduced expression of NF-κB, phospho-inhibitor kappa B-alpha, MLCK and phospho-myosin light-chain-2 by 16.06% (P < 0.05), 54.31% (P < 0.05), 66.10% (P < 0.05) and 64.82% (P < 0.05), respectively.

Conclusion: ASPS pretreatment may be associated with inhibition of the NF-κB/MLCK pathway and concomitant amelioration of LPS-induced TJ dysfunction of intestinal epithelium in endotoxemia.

Keywords: Acanthopanax senticosus polysaccharide; Intestinal permeability; Myosin light chain kinase; Nuclear factor-kappa B; Tight junction.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: The authors declare that there are no conflicts of interest related to this study.

Figures

Figure 1
Figure 1
Effects of acanthopanax senticosus polysaccharides on clinical score, macroscopic features of distal ileum and colon, histological appearance and score of distal ileum in lipopolysaccharide-induced mice. A: Mice were assessed for clinical score at designated time points after lipopolysaccharide (LPS) challenge (n = 8); B: Representative photographs of the distal ileums and colons at 6 h after LPS injection (n = 8); C: Effects of acanthopanax senticosus polysaccharides (ASPS) on LPS-induced intestinal histopathologic changes. Ileum was processed for morphological and histopathologic evaluation at 6 h after LPS induction (n = 3). The representative photomicrographs of ileal segments stained with hematoxylin and eosin at 200 × magnification of C1, control group; C2, LPS group; C3, ASPS + LPS group; and C4, LPS + ASPS group; D: Intestinal histopathologic score was determined at 6 h after LPS challenge (n = 3); E: Effects of ASPS on LPS-induced increase in iliac mucosal permeability. The intestinal permeability of 4 kDa fluorescein isothiocyanate (FITC)-dextran in ileal pouch was measured at 2, 4 and 6 h after LPS administration (n = 8). aP < 0.05, vs the control group; cP < 0.05, vs the LPS group.
Figure 2
Figure 2
Localization and expression of tight junction proteins, and tight junction proteins ultrastructure in ileum were evaluated 6 h after lipopolysaccharide administration in mice of four groups. A: Effects of Acanthopanax senticosus polysaccharides (ASPS) on distribution of occludin and ZO-1. Staining of both proteins along the villous epithelium at a 200 × magnification (red fluorescence) were observed by immunofluorescence. Nuclei were stained by DAPI (blue fluorescence). Arrows indicate the location of tight junction (TJ) proteins staining; B: Effects of ASPS on intestinal TJ proteins expression of occludin and ZO-1 (n = 3). Protein samples were analyzed by western blotting, and β-actin was used as an internal control. The values are presented as mean ± SE. aP < 0.05, vs the control group; cP < 0.05, vs the LPS group; C: Effects of ASPS on intestinal TJ ultrastructure in ileum viewed under transmission electron microscope of C1, control group; C2, LPS group; C3, ASPS + LPS group; and C4, LPS + ASPS group. Arrows indicate the location of the TJ (scale bar = 1 μm).
Figure 3
Figure 3
Protein expression of phospho-IκBα, nuclear factor-kappa B p65, myosin light chain kinase and phospho-MLC2 (A) and MLCK localization (B) in ileum epithelium. A: Protein expression of phospho-IκBα (A1), nuclear factor-kappa B (NF-κB) p65 (A2), myosin light chain kinase (MLCK) (A3) and phospho-MLC2 (A4) were analyzed by western blotting at 6 h after lipopolysaccharide (LPS) induction, and β-actin was used as internal control (n = 3). Data are shown as mean ± SE (n = 3). aP < 0.05, vs the control group; cP < 0.05, vs the LPS group; B: MLCK location was observed by immunofluorescence at 6 h after LPS administration at 200 × magnification (red fluorescence) (n = 3). Nuclei were stained by DAPI (blue fluorescence).

References

    1. Angus DC, Wax RS. Epidemiology of sepsis: an update. Crit Care Med. 2001;29:S109–S116. - PubMed
    1. Polderman KH, Girbes AR. Drug intervention trials in sepsis: divergent results. Lancet. 2004;363:1721–1723. - PubMed
    1. Hassoun HT, Kone BC, Mercer DW, Moody FG, Weisbrodt NW, Moore FA. Post-injury multiple organ failure: the role of the gut. Shock. 2001;15:1–10. - PubMed
    1. Lee SH. Intestinal permeability regulation by tight junction: implication on inflammatory bowel diseases. Intest Res. 2015;13:11–18. - PMC - PubMed
    1. De-Souza DA, Greene LJ. Intestinal permeability and systemic infections in critically ill patients: effect of glutamine. Crit Care Med. 2005;33:1125–1135. - PubMed

LinkOut - more resources